文献速递血液净化与透析

透析中肾脏康复与死亡率:REVEAL-D登记研究结果

Intradialytic Renal Rehabilitation and Mortality: Results from the Registry of Active Renal Rehabilitation in Dialysis Patients (REVEAL-D).
PubMed 文献 · Clin J Am Soc Nephrol · 2026-07-10

康复组228例接受每周至少1次、持续至少1个月的监督下透析中运动指导加营养和生活方式指导,非康复组480例。结果显示康复组3年生存率更高(84.6% vs 75.6%),调整后死亡风险降低,尤其在男性和严重衰弱患者中更明显。

要点

  • 透析中肾脏康复与维持性血液透析患者更高的3年生存率相关。
  • 多变量调整和倾向评分匹配后关联方向一致,男性及严重衰弱者似乎更强。
  • 未报告与康复相关的不良事件。

核心结论

  • 透析中肾脏康复可能与维持性血液透析患者更好的生存相关,尤其在男性和严重衰弱患者中。

研究设计与样本

  • 康复定义为监督下透析中运动指导加营养和生活方式指导,每周至少1次、持续至少1个月。
  • 采用Cox回归模型和倾向评分匹配比较3年死亡率,调整临床衰弱量表、合并症、实验室数据及其他基线特征。

主要发现

  • 随访期间康复组死亡14.9%,非康复组死亡23.1%(P=0.01)。
  • 康复组3年生存率84.6%,非康复组75.6%(P=0.007),在男性和严重衰弱者中尤为明显。
  • Cox模型中康复与较低死亡率相关:粗HR 0.59(95%CI 0.40-0.87),调整HR 0.66(95%CI 0.44-1.00)。
  • 倾向评分匹配后关联方向相似(HR 0.65,95%CI 0.40-1.05)。
  • 性别分层分析提示男性关联更强(调整HR 0.49,95%CI 0.27-0.89),女性调整HR 0.98(95%CI 0.54-1.77),交互检验P=0.13。

临床怎么用

  • 对维持性血液透析患者可考虑提供监督下透析中运动指导联合营养和生活方式指导。
  • 男性和严重衰弱患者可能是优先受益人群。

局限性

  • 为回顾性研究设计。
  • 交互检验未达统计学显著性。
  • 倾向评分匹配后关联的置信区间包含1。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Intradialytic renal rehabilitation was associated with higher 3-year survival in patients on maintenance hemodialysis. This association was directionally consistent after multivariable adjustment and propensity score matching. The association seemed stronger in men with severe frailty; no rehabilitation-related adverse events were reported. BACKGROUND: Frailty and sarcopenia are increasingly common among patients undergoing maintenance hemodialysis. Globally, some countries, including Japan, have recently introduced insurance reimbursement for intradialytic renal rehabilitation, a supervised intradialytic exercise instruction plus nutritional and lifestyle guidance. However, the survival benefit has not been fully evaluated. METHODS: We evaluated 708 adult outpatients on dialysis (age, 69.8±11.2 years; men, 59%; and Clinical Frailty Scale ≥6, 13%) at ten institutions across Japan in January 2021 who were retrospectively assessed over a 3-year period, including 228 patients who received intradialytic renal rehabilitation, defined as supervised intradialytic exercise instruction plus nutritional and lifestyle guidance (≥1 session/wk for≥1 month), and 480 who did not receive this intervention. Cox regression models and propensity score matching were used to compare 3-year mortality after adjustment for the Clinical Frailty Scale, comorbidities, laboratory data, and other baseline characteristics. RESULTS: During the follow-up, deaths were observed in 14.9% of the rehabilitation group and 23.1% of the nonrehabilitation group ( P = 0.01). Three-year survival was higher with rehabilitation (84.6% versus 75.6%, P = 0.007), particularly among men and those with severe frailty. In Cox models, renal rehabilitation was consistently associated with lower mortality (crude hazard ratio [HR], 0.59 [95% confidence interval (CI), 0.40 to 0.87]; adjusted HR 0.66 [0.44 to 1.00]). After propensity score matching, the association remained directionally similar (HR, 0.65 [0.40 to 1.05]). Sex-stratified analyses suggested a stronger association among men (adjusted HR, 0.49 [0.27 to 0.89]) than among women (adjusted HR, 0.98 [0.54 to 1.77]), although the formal test for interaction was not statistically significant ( P for interaction = 0.13). Patients meeting exercise-habit criteria (≥2 sessions/wk, ≥30 minutes for ≥1 year) also showed better survival relative to the nonexercise-habit group (adjusted HR 0.60 [0.37 to 0.96], P = 0.03). No adverse events related to rehabilitation were reported. CONCLUSIONS: Intradialytic renal rehabilitation may be associated with better survival in patients on maintenance hemodialysis, particularly in men and in those with severe frailty.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hoshino J, Kida K, Kobayashi S, et al. Intradialytic Renal Rehabilitation and Mortality: Results from the Registry of Active Renal Rehabilitation in Dialysis Patients (REVEAL-D). Clin J Am Soc Nephrol. 2026. PMID: 42455635. doi:10.2215/CJN.0000001133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。